Directory
>
Jonathan Leith
Jonathan Leith
Vice President, Early Development Program Leads, Hematology, Oncology and Cell Therapy. | BRISTOL MYERS SQUIBB FARMACEUTICA
United States
Jonathan Leith
Summary
Jonathan Leith is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as Vice President, Early Development Program Lead at Bristol-Myers Squibb. With a robust educational background, including a PhD in Immunology/Virology from the University of Toronto, he has dedicated over two decades to advancing drug development and clinical research. Jonathan's expertise spans across various therapeutic areas including hematology, oncology, and infectious diseases. He has led cross-functional teams through critical development phases, showcasing his strong leadership capabilities. His role involves overseeing a diverse pipeline of assets, further solidifying his position as a key player in early drug development. Jonathan is passionate about leveraging innovative approaches to enhance patient outcomes in complex disease areas. His commitment to advancing medical science is evident in his strategic contributions to clinical trials and regulatory affairs.
Jonathan Leith
Work Experience
Vice President, Early Development Program Leads, Hematology, Oncology and Cell Therapy. at
Bristol Myers Squibb
April 2024 - Present
Vice President, Early Development Program Lead at
BRISTOL MYERS SQUIBB FARMACEUTICA
November 2019 - Present
Vice President Full Development Lead Hematology at
BRISTOL MYERS SQUIBB FARMACEUTICA
February 2016 - November 2019
Vice President Full Development Lead, Immuno-Oncology and Oncology; IO Strategy. at
Bristol Myers Squibb Princeton New Jersey
November 2010 - November 2019
Head of Clinical Mechanisms, Translational Medicine at
BRISTOL MYERS SQUIBB FARMACEUTICA
March 2018 - November 2019
Vice President, Development Lead, Breast Cancer and Hematology, Oncology Development at
BRISTOL MYERS SQUIBB FARMACEUTICA
September 2017 - November 2019
Vice President, Full Development Lead Oncology at
BRISTOL MYERS SQUIBB FARMACEUTICA
February 2010 - December 2010
Therapeutic Lead Director Virology and Oncology at
Tibotec
January 2008 - January 2010
Director Clinical at
Tibotec Johnson And Johnson
January 2006 - January 2008
Clinical, Director at
Tibotec Canada A Division Of Janssen Ortho
January 2006 - February 2007
Global Medical Lead VIRAMUNE at
Boehringer Ingelheim (schweiz) Gmbh
February 2004 - August 2006
Immunology at
Bi Etc
January 2001 - January 2003
Jonathan Leith
Education
January 1997 - January 2001
McMaster University, M.Sc
January 1995 - January 1997
McMaster University, Msc
January 1990 - January 1994
Frequently Asked Questions about Jonathan Leith
What is Jonathan Leith email address?
Jonathan Leith's primary email address is **************@bms.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jonathan Leith work for?
Jonathan Leith is a Vice President, Early Development Program Leads, Hematology, Oncology and Cell Therapy. at BRISTOL MYERS SQUIBB FARMACEUTICA, a company specializing in Diagnostic substances.
Where Jonathan Leith graduated from?
Jonathan Leith holds a degree in Immunology / Virology from University of Toronto.
How can I directly contact Jonathan Leith?
To contact Jonathan Leith directly, you can use the email address **************@bms.com. Complete contact information is available upon registration with Muraena.
Who is Jonathan Leith?
Jonathan Leith is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as Vice President, Early Development Program Lead at Bristol-Myers Squibb. With a robust educational background, including a PhD in Immunology/Virology from the University of Toronto, he has dedicated over two decades to advancing drug development and clinical research. Jonathan's expertise spans across various therapeutic areas including hematology, oncology, and infectious diseases. He has led cross-functional teams through critical development phases, showcasing his strong leadership capabilities. His role involves overseeing a diverse pipeline of assets, further solidifying his position as a key player in early drug development. Jonathan is passionate about leveraging innovative approaches to enhance patient outcomes in complex disease areas. His commitment to advancing medical science is evident in his strategic contributions to clinical trials and regulatory affairs.
Jonathan`s contact details
**************@bms.com
******@bristol.com.br
Colleagues
Executive Director Business Development, Transactions
Executive Vice President, General Counsel
Executive Director Finance, US Commercialization FP&A
Executive Director, GCR
VP, Global development Program Lead
Senior Print and Premium Specialist
Executive Director, Head of Immunology and Neuroscience Chemistry
Scientific Vice President
Executive Director | Head of Strategy & Operations | Chief of Staff